Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23633004

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2013 Aug 1
First author
Kantarjian H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2013 Aug 1;119(15):2671-4. doi: 10.1002/cncr.28135.
    note
    Source null
    related pmid
    23633448
    relationship
    Comment in

Authors and identifiers

  1. name
    Kantarjian H
    type
    Author
  2. name
    Thomas D
    type
    Author
  3. name
    Jorgensen J
    type
    Author
  4. name
    Kebriaei P
    type
    Author
  5. name
    Jabbour E
    type
    Author
  6. name
    Rytting M
    type
    Author
  7. name
    York S
    type
    Author
  8. name
    Ravandi F
    type
    Author
  9. name
    Garris R
    type
    Author
  10. name
    Kwari M
    type
    Author
  11. name
    Faderl S
    type
    Author
  12. name
    Cortes J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kantarjian H
    type
    Author
  2. name
    Thomas D
    type
    Author
  3. name
    Jorgensen J
    type
    Author
  4. name
    Kebriaei P
    type
    Author
  5. name
    Jabbour E
    type
    Author
  6. name
    Rytting M
    type
    Author
  7. name
    York S
    type
    Author
  8. name
    Ravandi F
    type
    Author
  9. name
    Garris R
    type
    Author
  10. name
    Kwari M
    type
    Author
  11. name
    Faderl S
    type
    Author
  12. name
    Cortes J
    type
    Author
bibliography ids
  1. nci-bib-eda1081ddd55e3dd9f39e3c3
book metadata
content sha256
b1bcc98370f33f1159e415c0cf803b5b0c49dcce193f00057b8855a0db922d1d
document type
citation
dois
  1. 10.1002/cncr.28136
electronic publication date
display
2013 Apr 30
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23633004
immutable id
pubmed:23633004@b1bcc98370f33f1159e415c0cf803b5b0c49dcce193f00057b8855a0db922d1d
journal
abbreviation
Cancer
issn electronic
1097-0142
issn print
0008-543X
issue
15
name
Cancer
nlm unique id
0374236
pages
2728-36
volume
119
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2013 Aug 1;119(15):2671-4. doi: 10.1002/cncr.28135.
    note
    Source null
    related pmid
    23633448
    relationship
    Comment in
outcomes validated
false
pmid
23633004
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
b3f298918a6bc67e77f9622a3b306d4d67c1473c715c44c3299c3159c731a83c
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 Aug 1
precision
day
year
2013
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23633004/
title
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.

Preserved source evidence · Not medical advice